Core Scientific, Tranche Stock EBITDA
| CORZZ Stock | 14.10 0.29 2.02% |
Core Scientific, Tranche fundamentals help investors to digest information that contributes to Core Scientific,'s financial success or failures. It also enables traders to predict the movement of Core Stock. The fundamental analysis module provides a way to measure Core Scientific,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Core Scientific, stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -56.8 M | -54 M |
Core | EBITDA |
Core Scientific, Tranche Company EBITDA Analysis
Core Scientific,'s EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Core Scientific, EBITDA | (63.12 M) |
Most of Core Scientific,'s fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Scientific, Tranche is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Core EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Core Scientific, is extremely important. It helps to project a fair market value of Core Stock properly, considering its historical fundamentals such as EBITDA. Since Core Scientific,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Core Scientific,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Core Scientific,'s interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Core Ebitda
According to the company disclosure, Core Scientific, Tranche reported earnings before interest,tax, depreciation and amortization of (63.12 Million). This is 106.82% lower than that of the Technology sector and 101.99% lower than that of the Software - Infrastructure industry. The ebitda for all United States stocks is 101.62% higher than that of the company.
Core EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Scientific,'s direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Scientific, could also be used in its relative valuation, which is a method of valuing Core Scientific, by comparing valuation metrics of similar companies.Core Scientific, is currently under evaluation in ebitda category among its peers.
Core Fundamentals
| Return On Asset | 0.0261 | ||||
| Profit Margin | (2.23) % | ||||
| Operating Margin | (0.43) % | ||||
| Number Of Shares Shorted | 43.66 K | ||||
| Revenue | 502.4 M | ||||
| EBITDA | (63.12 M) | ||||
| Net Income | (246.49 M) | ||||
| Total Debt | 865.54 M | ||||
| Book Value Per Share | (2.61) X | ||||
| Cash Flow From Operations | 65.11 M | ||||
| Number Of Employees | 286 | ||||
| Total Asset | 712.16 M | ||||
| Retained Earnings | (2.42 B) | ||||
| Working Capital | (391.41 M) | ||||
| Net Asset | 712.16 M |
About Core Scientific, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Core Scientific, Tranche's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Scientific, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Scientific, Tranche based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Core Stock Analysis
When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.